April 3rd 2025
View our Q1 2025 recap of standout pediatric news from FDA regulatory updates, clinical trial results, and expert commentary.
March 27th 2025
Peter Lio, MD, offers thoughts on recent atopic dermatitis data reported for lebrikizumab.
March 10th 2025
The newest tapinarof results were presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting.
March 7th 2025
Lebrikizumab improves itch, sleep interference, and skin pain in atopic dermatitis patients previously treated with dupilumab, offering a new treatment option.
February 26th 2025
The application is for children aged 2 to 5 years with mild-to-moderate atopic dermatitis.
Infographics make educating parents about AD easier
For diseases such as atopic dermatitis (AD) that require complex care, colorful infographics take the guesswork out of patient education.
Healing both body and mind in atopic dermatitis
Children with atopic dermatitis (AD) will go to great lengths to hide their skin. Here’s how referring them to a pediatric psychologist can help them be their best self, even with AD.
How atopic dermatitis impacts sleep quality and duration (VIDEO)
For Contemporary Pediatrics, Dr Bobby Lazzara discusses a study published in JAMA Pediatrics that examined how atopic dermatitis impacted the sleep quality and duration of the 14,000 study participants.
Microbiome-based therapy for eczema: On the horizon?
New research examined the potential role of Gram-negative skin bacteria in the pathogenesis and exacerbation of eczema, and their effectiveness to treat it.